DocDollars

Duchesnay USA Incorporated

NJ · United States · Reporting entity ID 100000000315

Total reported 2019–2025
$1.10M
#1,271 of 2,960 reporting companies — 0% of all reported industry payments
$981K in general payments across 10,081 records, plus $117K in research funding across 30 records.

How it breaks down

General payments $981,306
Research funding $117,073

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Duchesnay USA Incorporated reported $1.10M to US doctors and teaching hospitals from 2019 to 2025, ranking #1,271 of 2,960 reporting companies. 11% of that was research funding and 89% general payments such as consulting, speaking, food and travel. 10,081 general payment records and 30 research records were filed.

Common questions about Duchesnay USA Incorporated

How much has Duchesnay USA Incorporated paid US doctors?

Duchesnay USA Incorporated reported $1,098,379 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $981,306 in general payments, $117,073 in research funding.

How does Duchesnay USA Incorporated rank among drug and device companies?

It ranks #1,271 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Duchesnay USA Incorporated mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.